↓ Skip to main content

Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy

Overview of attention for article published in Angiogenesis, July 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
80 Mendeley
Title
Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy
Published in
Angiogenesis, July 2014
DOI 10.1007/s10456-014-9438-1
Pubmed ID
Authors

Sanne de Haas, Paul Delmar, Aruna T. Bansal, Matthieu Moisse, David W. Miles, Natasha Leighl, Bernard Escudier, Eric Van Cutsem, Peter Carmeliet, Stefan J. Scherer, Celine Pallaud, Diether Lambrechts

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 1%
Belgium 1 1%
Unknown 78 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 15%
Other 10 13%
Researcher 8 10%
Student > Master 7 9%
Student > Doctoral Student 6 8%
Other 18 23%
Unknown 19 24%
Readers by discipline Count As %
Medicine and Dentistry 36 45%
Biochemistry, Genetics and Molecular Biology 8 10%
Agricultural and Biological Sciences 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Engineering 3 4%
Other 7 9%
Unknown 17 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2019.
All research outputs
#6,286,217
of 22,813,792 outputs
Outputs from Angiogenesis
#142
of 536 outputs
Outputs of similar age
#59,137
of 226,494 outputs
Outputs of similar age from Angiogenesis
#3
of 6 outputs
Altmetric has tracked 22,813,792 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 536 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,494 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.